Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

172 та иш

Иш: The Radioprotective Potentials of Silymarin/Silibinin Against Radiotherapy-Induced Toxicities: A Systematic Review of Clinical and ExperimentalStudies

  1. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver

    Nirav Patel, Cecil K. Joseph, George B. Corcoran +1

    Мақола20103 иқтибос
    ABI

  2. Identification of novel mechanisms of silymarin on the carbon tetrachloride-induced liver fibrosis in mice by nuclear factor-κB bioluminescent imaging-guided transcriptomic analysis

    Chia‐Cheng Li, Chien‐Yun Hsiang, Shih‐Lu Wu +1

    Мақола20123 иқтибос
    ABI

  3. An Updated Systematic Review with Meta-Analysis for the Clinical Evidence of Silymarin

    Reinhard Saller, Reto Brignoli, Jörg Melzer +1

    Шарҳ мақола20083 иқтибос
    ABI

  4. Multitargeted therapy of cancer by silymarin

    Kumaraguruparan Ramasamy, Rajesh Agarwal

    Шарҳ мақола20083 иқтибос
    ABI

  5. Silymarin Prevents Palmitate‐Induced Lipotoxicity in HepG2 Cells: Involvement of Maintenance of Akt Kinase Activation

    Zhenyuan Song, Ming Song, David Y.W. Lee +3

    Мақола20073 иқтибос
    ABI

  6. Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells

    M. Trappoliere, Alessandra Caligiuri, Monika Schmid +8

    Мақола20093 иқтибос
    ABI

  7. Antioxidant, anti-inflammatory and hepatoprotective effects of silymarin on hepatic dysfunction induced by sodium nitrite

    Imam O. Sherif, Mohammed M.H. Al-Gayyar

    Мақола20133 иқтибос
    ABI

  8. Silymarin in the treatment of liver diseases: What is the clinical evidence?

    Peter Ferenci

    Мақола20163 иқтибос
    ABI

  9. Effects of benzo[a]pyrene as an environmental pollutant and two natural antioxidants on biomarkers of reproductive dysfunction in male rats

    Salah A. Sheweita, S. Al-Shora, Marwa Hassan

    Мақола20163 иқтибос
    ABI

  10. Modulatory effect of silymarin on pulmonary vascular dysfunction through HIF-1α-iNOS following rat lung ischemia-reperfusion injury

    Yanwu Jin, Xin Zhao, He Zhang +3

    Мақола20163 иқтибос
    ABI

  11. Silymarin preconditioning protected insulin resistant rats from liver ischemia-reperfusion injury: role of endogenous H2S

    N. Younis, Mohamed A. Shaheen, Mona F. Mahmoud

    Мақола20163 иқтибос
    ABI

  12. Modulatory effect of silymarin on nuclear factor-erythroid-2-related factor 2 regulated redox status, nuclear factor-κB mediated inflammation and apoptosis in experimental gastric ulcer

    Walaa A. Keshk, Samer Zahran, Mohamed Katary +1

    Мақола20173 иқтибос
    ABI

  13. Evaluation of oral nano-silymarin formulation efficacy on prevention of radiotherapy induced mucositis: A randomized, double-blinded, placebo-controlled clinical trial

    Sare Hosseini, Sina Rezaei, M.R. Niazi Moghadam +2

    Мақола20213 иқтибос
    ABI

  14. A review on the mechanisms of the effect of silymarin in milk thistle ( <i>Silybum marianum</i> ) on some laboratory animals

    Roshanak Khazaei, Alireza Seidavi, Mehrdad Bouyeh

    Шарҳ мақола20213 иқтибос
    ABI

  15. Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome <i>c</i> release, and caspase activation

    Santosh K. Katiyar, Anshu M. Roy, Manjeshwar Shrinath Baliga

    Мақола20053 иқтибос
    ABI

  16. Silymarin Suppresses TNF-Induced Activation of NF-κB, c-Jun N-Terminal Kinase, and Apoptosis

    Sunil K. Manna, Asok Mukhopadhyay, Nguyen T. Van +1

    Мақола19993 иқтибос
    ABI

  17. The <scp>MAPK</scp> pathway across different malignancies: A new perspective

    Mauricio Burotto, Victoria L. Chiou, Jung‐Min Lee +1

    Шарҳ мақола20143 иқтибос
    ABI

  18. Radiation–Induced Signaling Results in Mitochondrial Impairment in Mouse Heart at 4 Weeks after Exposure to X-Rays

    Žarko Barjaktarović, Dominik Schmaltz, Alena Shyla +9

    Мақола20113 иқтибос
    ABI

  19. Strategies for optimizing the response of cancer and normal tissues to radiation

    Everett J. Moding, Michael B. Kastan, David G. Kirsch

    Шарҳ мақола20133 иқтибос
    ABI

  20. Chronic Inflammation in Cancer Development

    Gabriele Multhoff, M. Molls, Jürgen Radons

    Мақола20123 иқтибос
    ABI

  21. Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp‐9) and effector caspases (casp‐3/casp‐7) and PARP in UVR‐exposed HaCaT keratinocytes

    Tobias W. Fischer, Michał A. Żmijewski, Jacobo Wortsman +1

    Мақола20073 иқтибос
    ABI

  22. Alpha-lipoic acid inhibits hepatic PAI-1 expression and fibrosis by inhibiting the TGF-β signaling pathway

    Ae-Kyung Min, Mi Kyung Kim, Hye‐Young Seo +7

    Мақола20103 иқтибос
    ABI

  23. Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis

    Reiner U. Jänicke, Michael L. Sprengart, Mas Rina Wati +1

    Мақола19983 иқтибос
    ABI

  24. Silymarin and its constituents in cardiac preconditioning

    Aleksey Zholobenko, Martin Modrianský

    Шарҳ мақола20143 иқтибос
    ABI

  25. p38 MAP KINASE REGULATES TNF-α PRODUCTION IN HUMAN ASTROCYTES AND MICROGLIA BY MULTIPLE MECHANISMS

    Yong B. Lee, John W. Schrader, S.U Kim

    Мақола20003 иқтибос
    ABI